Correlation Between PolyPid and Cell Source

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PolyPid and Cell Source at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PolyPid and Cell Source into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PolyPid and Cell Source, you can compare the effects of market volatilities on PolyPid and Cell Source and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PolyPid with a short position of Cell Source. Check out your portfolio center. Please also check ongoing floating volatility patterns of PolyPid and Cell Source.

Diversification Opportunities for PolyPid and Cell Source

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between PolyPid and Cell is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding PolyPid and Cell Source in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cell Source and PolyPid is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PolyPid are associated (or correlated) with Cell Source. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cell Source has no effect on the direction of PolyPid i.e., PolyPid and Cell Source go up and down completely randomly.

Pair Corralation between PolyPid and Cell Source

Given the investment horizon of 90 days PolyPid is expected to generate 2.69 times less return on investment than Cell Source. But when comparing it to its historical volatility, PolyPid is 2.72 times less risky than Cell Source. It trades about 0.1 of its potential returns per unit of risk. Cell Source is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  26.00  in Cell Source on May 15, 2025 and sell it today you would earn a total of  9.00  from holding Cell Source or generate 34.62% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

PolyPid  vs.  Cell Source

 Performance 
       Timeline  
PolyPid 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in PolyPid are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, PolyPid exhibited solid returns over the last few months and may actually be approaching a breakup point.
Cell Source 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Cell Source are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental indicators, Cell Source unveiled solid returns over the last few months and may actually be approaching a breakup point.

PolyPid and Cell Source Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PolyPid and Cell Source

The main advantage of trading using opposite PolyPid and Cell Source positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PolyPid position performs unexpectedly, Cell Source can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cell Source will offset losses from the drop in Cell Source's long position.
The idea behind PolyPid and Cell Source pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk